Merck & Co Inc (MRK)
109.77
-0.41
(-0.37%)
USD |
NYSE |
Oct 04, 16:00
109.59
-0.18
(-0.16%)
Pre-Market: 20:00
Merck Shareholders Equity (Annual): 37.58B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.58B |
| December 31, 2022 | 45.99B |
| December 31, 2021 | 38.18B |
| December 31, 2020 | 25.32B |
| December 31, 2019 | 25.91B |
| December 31, 2018 | 26.70B |
| December 31, 2017 | 34.34B |
| December 31, 2016 | 40.09B |
| December 31, 2015 | 44.68B |
| December 31, 2014 | 48.65B |
| December 31, 2013 | 49.76B |
| December 31, 2012 | 53.02B |
| December 31, 2011 | 54.52B |
| December 31, 2010 | 54.38B |
| December 31, 2009 | 59.06B |
| December 31, 2008 | 18.76B |
| December 31, 2007 | 18.18B |
| December 31, 2006 | 17.56B |
| December 31, 2005 | 17.98B |
| December 31, 2004 | 17.29B |
| Date | Value |
|---|---|
| December 31, 2003 | 15.58B |
| December 31, 2002 | 18.20B |
| December 31, 2001 | 16.05B |
| December 31, 2000 | 14.83B |
| December 31, 1999 | 13.24B |
| December 31, 1998 | 12.80B |
| December 31, 1997 | 12.59B |
| December 31, 1996 | 11.97B |
| December 31, 1995 | 11.74B |
| December 31, 1994 | 11.14B |
| December 31, 1993 | 10.02B |
| December 31, 1992 | 5.003B |
| December 31, 1991 | 4.916B |
| December 31, 1990 | 3.834B |
| December 31, 1989 | 3.521B |
| December 31, 1988 | 2.856B |
| December 31, 1987 | 2.117B |
| December 31, 1986 | 2.569B |
| December 31, 1985 | 2.634B |
| December 31, 1984 | 2.544B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
25.32B
Minimum
2020
45.99B
Maximum
2022
34.60B
Average
37.58B
Median
2023
Shareholders Equity (Annual) Benchmarks
| Amgen Inc | 6.232B |
| Johnson & Johnson | 68.77B |
| Eli Lilly and Co | 10.77B |
| Pfizer Inc | 89.01B |
| Moderna Inc | 13.85B |